α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin
dc.contributor.author | Ute A. Schwinghammer, Magda M. Melkonyan, Lilit Hunanyan, Roman Tremmel, Ralf Weiskirchen, Erawan Borkham-Kamphorst, Elke Schaeffeler, Torgom Seferyan, Wolfgang Mikulits, Konstantin Yenkoyan, Matthias Schwab, Lusine Danielyan | |
dc.date.accessioned | 2022-11-29T06:34:17Z | |
dc.date.available | 2022-11-29T06:34:17Z | |
dc.date.issued | 2020-02-18 | |
dc.identifier.uri | https://dspace.ysmu.am/handle/555555555/58 | |
dc.language.iso | en | |
dc.title | α2-Adrenergic Receptor in Liver Fibrosis: Implications for the Adrenoblocker Mesedin | |
dspace.entity.type |